Bibliographic Details
| Title: |
HIF Prolyl Hydroxylase Inhibitors Prevent Neuronal Death Induced by Mitochondrial Toxins: Therapeutic Implications for Huntington's Disease and Alzheimer's Disease. |
| Authors: |
Zoya Niatsetskaya, Manuela Basso, Rachel E. Speer, Stephen J. McConoughey, Giovanni Coppola, Thong C. Ma, Rajiv R. Ratan |
| Source: |
Antioxidants & Redox Signaling. Feb2010, Vol. 12 Issue 4, p435-443. 9p. |
| Subject Terms: |
*OXYGENASES, *ENZYME inhibitors, *CELL death, *NEURONS, *MITOCHONDRIAL pathology, *NEURODEGENERATION, *HUNTINGTON'S chorea treatment, *ALZHEIMER'S disease treatment, *PREVENTION |
| Abstract: |
AbstractMitochondrial dysfunction is a central feature of a number of acute and chronic neurodegenerative conditions, but clinically approved therapeutic interventions are only just emerging. Here we demonstrate the potential clinical utility of low molecular weight inhibitors of the hypoxia inducible factor prolyl-4-hydroxylases (HIF PHDs) in preventing mitochondrial toxin-induced cell death in mouse striatal neurons that express a “knock-in” mutant Huntingtin allele. Protection from 3-nitropropionic acid (3-NP, a complex II inhibitor)-induced toxicity by HIF PHD inhibition occurs without rescue of succinate dehydrogenase activity. Although HIF-1α mRNA is dramatically induced by mutant huntingtin, HIF-1α depletion by short interfering RNAs (siRNA) does not affect steady-state viability or protection from 3-NP-induced death by HIF PHD inhibitors in these cells. Moreover, 3-NP-induced complex II inhibition in control or mutant striatal neurons does not lead to activation of HIF-dependent transcription. HIF PHD inhibition also protects cortical neurons from 3-NP-induced cytotoxicity. Protection of cortical neurons by HIF PHD inhibition correlates with enhanced VEGF but not PGC-1α gene expression. Together, these findings suggest that HIF PHD inhibitors are promising candidates for preventing cell death in conditions such as Huntington's disease and Alzheimer's disease that are associated with metabolic stress in the central nervous system. Antioxid. Redox Signal.12, 435–443. [ABSTRACT FROM AUTHOR] |
|
Copyright of Antioxidants & Redox Signaling is the property of Mary Ann Liebert, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
